يعرض 1,461 - 1,480 نتائج من 12,972 نتيجة بحث عن '(( significantly ((nn decrease) OR (larger decrease)) ) OR ( significant increase decrease ))', وقت الاستعلام: 0.49s تنقيح النتائج
  1. 1461
  2. 1462
  3. 1463
  4. 1464
  5. 1465

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  6. 1466

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  7. 1467

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  8. 1468
  9. 1469
  10. 1470
  11. 1471
  12. 1472
  13. 1473
  14. 1474
  15. 1475
  16. 1476
  17. 1477
  18. 1478
  19. 1479

    Simulation platform experimental data. حسب Qingsong Zhang (3353270)

    منشور في 2024
    الموضوعات:
  20. 1480